Virchow Biotech Pvt Ltd


Company		Team		Search		Site Map		Careers		Privacy Statement

Virchow Products

Biotech R&D

Our dedicated research facility is recognized by Government of India.

Our R&D center has a Doctoral Program (Ph.D) that is registered with Jawarlal Nehru Techonlogoical University, Osmania University, Nagarjuna University and Andhra University.

VBPL also has ongoing collaborative research projects with internationally reputable CSIR labs like Center for Cellular and Molecular Biology, Indian Institute of Chemical Technology, National Institutes of Nutrition and University of Michigan, USA.


Strategic Alliance
From the inception of the company the ability to develop alliances has been one of fundamental reasons for our success. Several marketed products and products in clinical development have arisen from such collaborations. We constantly seek to collaborate in areas where we see the potential for a good strategic fit. Virchow is dedicated to bringing considerable resources to the alliance, and is open to different collaboration structures.
We are open to assessing emerging technologies that can enhance our capabilities in Research & Development, Manufacturing, or Drug Delivery Please forward your proposals to: Business Development Department Virchow Biotech pvt Ltd. Plot No 4, S.V. Co-op Indl. Est IDA Jeedimetla Hyderabad -55 India

News & Events

Virchow Biotech is filing for U.S.Food and Drug administration’s (FDA) approval for its in house developed advanced wound care products.

Virchow Biotech received Drug control’s (DCGI) approval for conducting clinical trials on periogen, an indigenously developed recombinant therapeutic product for periodontal diseases

Virchow Biotech and Ranbaxy signed an MOU to market Virchow’s indigenously developed recombinant therapeutic protein for osteoporosis treatment. We are the first in the world to launch this biogeneric product